International Business (Roche Holding)

Abstract

Introduction Roche is a global medical firm that specialises in two segments: medications and diagnostics; whose headquarters are based in Switzerland. It is the largest biotechnology business in the world, with 17 pharmaceutical products on the market. Bio-pharmaceuticals make up more than half of Roche’s development portfolio, enabling them to deliver better-targeted medicines (About Roche, n.d). Following the company’s founding in 1896 in Basel, Switzerland, they have been dedicated to enhancing people’s lives, and Roche now develops cutting-edge medications and diagnostic procedures that benefit medical care beneficiaries across the world (About Roche, n.d). The company feels that having a defined sense of objectives can help them to navigate through a volatile and ever-changing world. Their goal is to achieve long-term, stable growth while providing value to all of the company’s stakeholders (About Roche, n.d). In accordance, with the global value chains in turbulent times, the company strives to cater to the stakeholders and remain competitive in the pharmaceuticals and diagnostics business. Further, the company has a prevalent global presence, operating in the United States of America (USA), Latin America, Europe, the Middle East, Japan and the Asia-Pacific region.